Maze Therapeutics (MAZE) AI Analysis
MAZE$34.33-1.76 -4.88%
Market cap$1.88BEnterprise value$1.96BRevenue (TTM)$20.00MMarket position—
Score
64
Neutral
Value
56
Quality
37
Growth
100
Maze Therapeutics doesn’t screen as a clean setup today — Stocklytics 64/100 leaves more to prove. Under the hood: revenue compounding ~-100% annually over recent years.